Inhibitors of the interaction between MDM2 and p53

Details for Australian Patent Application No. 2008300483 (hide)

Owner Janssen Pharmaceutica NV

Inventors Storck, Pierre-Henri; Schoentjes, Bruno; Ermert, Philipp; Piettre, Arnaud Marcel Pierre; Csoka, Imre Christian Francis; Poncelet, Virginie Sophie

Agent Shelston IP

Pub. Number AU-A-2008300483

PCT Pub. Number WO2009/037343

Priority 60/974,240 21.09.07 US; 07116897.5 21.09.07 EP

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/538 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/037343 Priority application(s): WO2009/037343

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008300495-Method for harvesting algae or plants and device used thereby

2008300478-Plants having increased yield-related traits and a method for making the same